Household Healthcare Sector

Prothena

Market Cap: US$386.5m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.

AngioDynamics

Market Cap: US$381.7m

A medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally.

Myriad Genetics

Market Cap: US$380.7m

A molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally.

Oruka Therapeutics

Market Cap: US$376.7m

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

MBX Biosciences

Market Cap: US$373.0m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

COMPASS Pathways

Market Cap: US$372.4m

Operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States.

Fulcrum Therapeutics

Market Cap: US$371.4m

A clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States.

ClearPoint Neuro

Market Cap: US$368.8m

Operates as a medical device company primarily in the United States.

Absci

Market Cap: US$367.4m

Operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.

NIOX Group

Market Cap: UK£274.8m

Engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide.

Erasca

Market Cap: US$364.0m

A clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

TruBridge

Market Cap: US$363.6m

Provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally.

Rapport Therapeutics

Market Cap: US$363.5m

Operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.

Emergent BioSolutions

Market Cap: US$360.4m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.

Faron Pharmaceuticals Oy

Market Cap: UK£267.9m

Operates as a clinical stage drug discovery and development company.

Nano-X Imaging

Market Cap: US$357.1m

Develops a commercial-grade tomographic imaging device with a digital X-ray source.

Mereo BioPharma Group

Market Cap: US$356.2m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

Rigel Pharmaceuticals

Market Cap: US$354.5m

A biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.

Autolus Therapeutics

Market Cap: US$354.0m

A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally.

Alpha Teknova

Market Cap: US$353.5m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

SBC Medical Group Holdings

Market Cap: US$352.3m

Provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.

Checkpoint Therapeutics

Market Cap: US$347.6m

A commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.

Humacyte

Market Cap: US$347.5m

Engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.

SNDL

Market Cap: US$347.3m

Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada.

Senseonics Holdings

Market Cap: US$346.8m

A commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.

Benitec Biopharma

Market Cap: US$346.7m

A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

Outset Medical

Market Cap: US$345.6m

A medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.

Clinuvel Pharmaceuticals

Market Cap: AU$531.6m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

TurnKey Capital

Market Cap: US$338.5m

HealthSpan Medical Systems, Inc. develops marijuana based intravenous therapy (IV) infusion blends for healthcare practitioners.

Cytek Biosciences

Market Cap: US$338.2m

A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

Mayne Pharma Group

Market Cap: AU$526.5m

A specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

UroGen Pharma

Market Cap: US$337.0m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

ORIC Pharmaceuticals

Market Cap: US$336.2m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.

Cryoport

Market Cap: US$334.9m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

Anbio Biotechnology

Market Cap: US$330.9m

Provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.

Cidara Therapeutics

Market Cap: US$330.7m

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.